ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 2418

The Transmembrane Protein Tyrosine Phosphatase Kappa Promotes Aggressiveness Of Rheumatoid Arthritis Fibroblast-Like Synoviocytes

Stephanie M. Stanford1, William B. Kiosses2, Amanda M. Campbell3, Michael F. Maestre3, David L. Boyle4, Gary S. Firestein4 and Nunzio Bottini3, 1Cellular Biology, La Jolla Institute for Allergy and Immunology, La Jolla, CA, 2The Scripps Research Institute, La Jolla, CA, 3La Jolla Institute for Allergy and Immunology, La Jolla, CA, 4Division of Rheumatology, Allergy and Immunology, University of California at San Diego School of Medicine, La Jolla, CA

Meeting: 2013 ACR/ARHP Annual Meeting

Keywords: Autoimmunity, Fibroblasts, pathogenesis, rheumatoid arthritis, signal transduction and synovial cells, synovial fluid

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Title: Rheumatoid Arthritis: Human Etiology and Pathogenesis II

Session Type: Abstract Submissions (ACR)

Background/Purpose: Fibroblast-like synoviocytes (FLS) in the synovial intimal lining are key mediators of inflammation and joint destruction in rheumatoid arthritis (RA). In RA these cells assume a tumor-like phenotype, aggressively invading the extracellular matrix and producing cartilage-degrading proteases and inflammatory cytokines. The behavior of synovial fibroblasts is controlled by multiple interconnected signal transduction pathways involving reversible protein phosphorylation. However, little is known about the role of protein tyrosine phosphatases (PTPs) in FLS function. The objective of this study was to identify PTPs involved in the aggressive phenotype of RA FLS. 

Methods: Comparative screening was conducted of PTP expression in FLS from patients with RA or osteoarthritis (OA) by quantitative polymerase chain reaction (PCR). The functional effect on RA FLS of protein tyrosine phosphatase kappa (RPTPκ), a transmembrane PTP that was up-regulated in RA, was then analyzed by knockdown using cell-permeable antisense oligonucleotides (ASO). Transwell FLS invasion assays were performed with Matrigel-coated inserts, using fetal bovine serum or platelet-derived growth factor as chemoattractants. FLS adhesion and spreading was assessed by F-actin staining with phalloidin and visualized by immunofluorescence microscopy. Expression levels of matrix metalloproteinases (MMPs) were quantified by qPCR. Western blotting of cell lysates using phosphospecific antibodies was used to assess activation of signaling pathways. Cell survival was measured by flow cytometry following staining with propidium iodide and Annexin V.

Results: Expression of PTPRK, encoding the protein tyrosine phosphatase RPTPκ, was increased in RA (n=16) compared to OA (n=15) FLS (1.99±0.68 fold increase, p<0.05). RPTPκ, a proposed transforming growth factor β (TGFβ) dependent gene, belongs to a family of PTPs that mediate cell-cell adhesion through homophilic interaction between their extracellular domains. We found that PTPRK expression is induced by stimulation of RA FLS with 50 ng/ml TGFβ1 for 24 hours (1.91±0.45 fold increase, p<0.05). Subsequent studies focused on the functional role of RPTPκ in RA FLS. Knockdown of this PTP with ASO led to impaired cell invasion (67.8±16.5% decrease, p<0.05). Although cell adhesion to an extracellular matrix was unaffected, RPTPκ deficiency disrupted cell spreading (40.2±12.7% decrease, p<0.05). RPTPκ-deficient RA FLS displayed more than 2-fold decreased TNF (50 ng/ml) or TGFβ-mediated induction of MMP1, MMP8, MMP10, MMP13 and MMP14, which correlated with reduced induction of JNK phosphorylation.

Conclusion: These findings indicate a novel role for RPTPκ as a key mediator of FLS function. RPTPκ promotes the invasiveness of RA FLS and, due to its higher expression in RA compared with OA FLS, could contribute to the unique “transformed” phenotype of rheumatoid cells. Therefore RPTPκ could be a novel therapeutic target for RA.


Disclosure:

S. M. Stanford,
None;

W. B. Kiosses,
None;

A. M. Campbell,
None;

M. F. Maestre,
None;

D. L. Boyle,
None;

G. S. Firestein,
None;

N. Bottini,
None.

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2013 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/the-transmembrane-protein-tyrosine-phosphatase-kappa-promotes-aggressiveness-of-rheumatoid-arthritis-fibroblast-like-synoviocytes/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology